Stephen Hahn Should Focus On Stability In First Days As US FDA Commissioner, Stakeholders Say

Among Hahn's primary duties should be to reassure staff that he will not be making radical changes and begin working on a priority list, experts told the Pink Sheet.

Stephen Hahn swearing in
HHS Secretary Alex Azar administered the oath of office to new FDA Commissioner Stephen Hahn. • Source: US Department of Health and Human Services

Stephen Hahn is beginning a whirlwind first few days as commissioner of the US Food and Drug Administration, where among his duties likely will be to reassure staff that the agency will continue on its current path.

Hahn was sworn in as commissioner at around 5:05 PM on 17 December by Alex Azar, shortly before the HHS...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA

More from Agency Leadership